Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer
Prostate cancer, a prevalent malignancy affecting the prostate gland, is a significant global health concern. Androgen-deprivation therapy (ADT) has proven effective in controlling advanced disease, with over 50% of patients surviving at the 10-year mark. However, a diverse spectrum of responses exi...
Saved in:
Main Authors: | Maurizio Capuozzo, Mariachiara Santorsola, Monica Ianniello, Francesco Ferrara, Andrea Zovi, Nadia Petrillo, Rosa Castiello, Maria Rosaria Fantuz, Alessandro Ottaiano, Giovanni Savarese |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-05-01
|
Series: | Diseases |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-9721/12/5/87 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
by: Takanobu Utsumi, et al.
Published: (2025-01-01) -
Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01) -
Utilization of patient-reported outcomes to assess adherence to relugolix when combined with stereotactic body radiation therapy for intermediate to high-risk prostate cancer
by: Kelly Gaudian, et al.
Published: (2025-01-01) -
Comprehensive analysis of the interaction microbiome and prostate cancer: an initial exploration from multi-cohort metagenome and GWAS studies
by: Gui-Chen Ye, et al.
Published: (2025-01-01) -
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer
by: Guansong Zheng, et al.
Published: (2025-02-01)